Physician profile
Ronald E Parfitt
NPI 1588674626
$5,078.15
in general payments reported to CMS, 2019-2025
34 companies · $867 in 2025
The $867 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $543 · 2021: $602 · 2022: $914 · 2023: $781 · 2024: $791 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,439.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,030.02 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $900.17 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $528.22 | 2019-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $432.89 | 2019-2025 | |
| Abbvie INC. | $398.91 | 2019-2025 | |
| Novo Nordisk INC | $333.22 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $212.37 | 2020-2024 | Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.75 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $196.75 | 2021-2024 | |
| Astellas Pharma US INC | $142.38 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $84.56 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Aimmune Therapeutics, INC. | $58.98 | 2025 | Zenpep |
| Exact Sciences Corporation | $55.68 | 2025 | Cologuard Collection Kit |
| Verona Pharma, INC. | $51.80 | 2025 | Ohtuvayre |
| Dexcom, INC. | $37.05 | 2022-2023 | Dexcom G6 Transmitter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $34.00 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Esperion Therapeutics, INC. | $30.78 | 2024-2025 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.72 | 2019 | |
| Amarin Pharma, INC. | $29.71 | 2020-2021 | |
| Mylan Specialty L.P. | $26.59 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $24.97 | 2022-2023 | |
| Organogenesis INC. | $24.54 | 2024 | Cygnus Dual |
| Viatris Specialty LLC | $23.32 | 2025 | Yupelri |
| Insulet Corporation | $22.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.08 | 2021 | |
| Xeris Pharmaceuticals, INC. | $21.35 | 2023 | Keveyis |
| Boston Scientific Corporation | $21.13 | 2024 | |
| Radius Health, INC. | $14.84 | 2021 | |
| Allergan, INC. | $13.41 | 2020 | |
| Paratek Pharmaceuticals, INC. | $13.36 | 2024 | Nuzyra |
| Janssen Pharmaceuticals, INC | $13.16 | 2020 | |
| Electromed, INC. | $13.07 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $12.51 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Parfitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.